CD19/CD20 Dual-CAR-T in B-cell Lymphoma Patients

Clinical trial NCT04260932 · COMPLETED

Trial details

NCT number: NCT04260932
Sponsor: Hebei Yanda Ludaopei Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Lymphoma

Start date: 2020-03-01
Primary completion: 2021-05-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.